PLUS THERAPEUTICS, INC. — Director's Dealing 2021

May 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2021-05-25

Reporting Person: Sims Andrew John Hugh MacIntyre (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-25	Stock Option (right to buy)	$2.25	A	100197	Acquired	2031-05-25	Common Stock (100197)	Direct

Footnotes

F1: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.